
China probes pricing at drugmakers including GSK, Merck
SHANGHAI (Reuters) - China's top economic planning agency is investigating costs and prices charged by drugmakers, including units of GlaxoSmithKline and Merck, as foreign firms come under pressure from Beijing...
